CONNECTIVE THERAPEUTICS INC has a total of 18 patent applications. Its first patent ever was published in 1993. It filed its patents most often in Australia, WIPO (World Intellectual Property Organization) and Canada. Its main competitors in its focus markets pharmaceuticals, biotechnology and measurement are AEGERION PHARMACEUTICALS INC, PROTEMIX DISCOVERY LTD and SOPHERION THERAPEUTICS INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | Australia | 7 | |
#2 | WIPO (World Intellectual Property Organization) | 7 | |
#3 | Canada | 2 | |
#4 | EPO (European Patent Office) | 1 | |
#5 | United States | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Measurement | |
#4 | Machines |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Peptides | |
#3 | Therapeutic chemical compounds | |
#4 | Analysing materials | |
#5 | Unspecified technologies | |
#6 | Measuring microorganism processes |
# | Name | Total Patents |
---|---|---|
#1 | Schwabe Christian | 8 |
#2 | Unemori Elaine | 7 |
#3 | Vandenbark Arthur Allen | 4 |
#4 | Vandenbark Arthur A | 3 |
#5 | Amento Edward P | 2 |
#6 | Buenafe Abigail Capistrano | 2 |
#7 | Enemori Elaine | 2 |
#8 | Amento Edward | 2 |
#9 | Offner Halina | 2 |
#10 | Erikson Mark | 2 |
Publication | Filing date | Title |
---|---|---|
AU6091696A | Treating immune deficiency diseases using t cell receptor pe ptides | |
WO9641167A1 | Relaxin diagnostic assays and kits, and methods and uses thereof | |
WO9601329A1 | Methods for diagnosing an immune-related disease and choosing an immune-related therapy | |
US5614192A | T cell receptor peptides as therapeutics for immune-related disease |